Viatris (VTRS) Non-Current Debt (2019 - 2026)

Viatris' (VTRS) quarterly Non-Current Debt came in at $12.4 billion in Q1 2026, down 12.44% year-on-year from $14.2 billion in Q1 2025, and down 0.54% quarter-over-quarter from $12.5 billion in Q4 2025.

Viatris (VTRS) Non-Current Debt (2019 - 2026) Analysis & Trends

Viatris' Non-Current Debt history runs 8 years deep, the most recent figure standing at $12.4 billion for Q1 2026.

  • On a quarterly basis, Non-Current Debt fell 12.44% year-over-year to $12.4 billion in Q1 2026; TTM through Mar 2026 was $12.4 billion, a 12.44% decrease from a year earlier, with the FY2025 full-year figure at $12.5 billion, down 11.1% from the prior year.
  • Non-Current Debt retreated to $12.4 billion in Q1 2026 per VTRS's latest filing, from $12.5 billion in the prior quarter.
  • Across five years, Non-Current Debt topped out at $19.2 billion in Q2 2022 and bottomed at $12.4 billion in Q1 2026.
  • The 5-year median for Non-Current Debt is $16.1 billion (2024), against an average of $15.7 billion.
  • Across the five-year window, Non-Current Debt fell 3.69% in 2023 and decreased 16.24% in 2024, its largest moves.
  • Year by year, Non-Current Debt stood at $18.0 billion in 2022, then fell by 10.14% to $16.2 billion in 2023, then dropped by 13.28% to $14.0 billion in 2024, then declined by 11.1% to $12.5 billion in 2025, then decreased by 0.54% to $12.4 billion in 2026.
  • Per Business Quant, the three latest VTRS Non-Current Debt figures stand at $12.4 billion (Q1 2026), $12.5 billion (Q4 2025), and $12.5 billion (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 10.34 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 14.02 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 9.05 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 27.86 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 12.41 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 3.74 Bn
10 Vireo Growth 10.57 Bn 10.41 Bn 59.30 Mn 197.30 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 12.41 Bn
Dec 31, 2025 12.48 Bn
Sep 30, 2025 12.49 Bn
Jun 30, 2025 12.79 Bn
Mar 31, 2025 14.18 Bn
Dec 31, 2024 14.04 Bn
Sep 30, 2024 14.30 Bn
Jun 30, 2024 14.73 Bn
Mar 31, 2024 16.07 Bn
Dec 31, 2023 16.19 Bn
Sep 30, 2023 17.08 Bn
Jun 30, 2023 17.25 Bn
Mar 31, 2023 18.07 Bn
Dec 31, 2022 18.02 Bn
Sep 30, 2022 18.72 Bn
Jun 30, 2022 19.21 Bn
Mar 31, 2022 18.76 Bn
Dec 31, 2021 19.72 Bn
Sep 30, 2021 19.85 Bn
Jun 30, 2021 20.92 Bn